Rachel N Grisham

No ORCID on file · 5 papers in corpus
other 2025
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc ·doi:10.1016/j.modpat.2025.100821

Clear cell adenocarcinoma of the urinary tract (utCCA) is a rare, Müllerian-type tumor typically arising in the urethra of female patients with poorly understood pathogenesis. Here, we report the clinical, pathologic, and molecular characte…

review 2025
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.101638

Mesonephric and mesonephric-like adenocarcinomas of the gynecologic tract are a rare subset of gynecologic tumors that are frequently associated with the presence of somatic KRAS mutations. Owing to their rare nature and ability to arise in…

observational 2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.01.015

OBJECTIVES: Mesonephric (MA) and mesonephric-like (MLA) adenocarcinomas are rare cancers, and data on clinical behavior and response to therapy are limited. We sought to report molecular features, treatment, and outcomes of MA/MLA from a si…

review 2022
JCO oncology practice ·doi:10.1200/op.21.00382

Pathogenic germline variants underlie up to 20% of ovarian cancer (OC) and are associated with varying degrees of risk for OC. For mutations in high-penetrance genes such as BRCA1/2, the role of risk-reducing bilateral salpingo-oophorectomy…

case-report 2017
Gynecologic oncology reports ·doi:10.1016/j.gore.2017.09.001

•Brain metastasis is an extremely rare secondary site of ovarian cancer metastasis.•Serous borderline tumor with brain metastasis has not been previously reported.•This is a rare case of brain metastasis in a patient with advanced serous bo…